Innovative estimation of survival using log-normal survival modelling on ACCENT database

BACKGROUND: The ACCENT database, with individual patient data for 20 898 patients from 18 colon cancer clinical trials, was used to support Food and Drug Administration (FDA) approval of 3-year disease-free survival as a surrogate for 5-year overall survival. We hypothesised substantive differences...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Chapman, J W, O'Callaghan, C J, Hu, N, Ding, K, Yothers, G A, Catalano, P J, Shi, Q, Gray, R G, O'Connell, M J, Sargent, D J
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2013
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3590670/
https://ncbi.nlm.nih.gov/pubmed/23385733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.34
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki